Aspen Pharunadr 1 Stock Fundamentals
| LDZU Stock | EUR 8.55 0.05 0.59% |
ASPEN PHARUNADR 1 fundamentals help investors to digest information that contributes to ASPEN PHARUNADR's financial success or failures. It also enables traders to predict the movement of ASPEN Stock. The fundamental analysis module provides a way to measure ASPEN PHARUNADR's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ASPEN PHARUNADR stock.
ASPEN |
ASPEN PHARUNADR 1 Company Return On Asset Analysis
ASPEN PHARUNADR's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current ASPEN PHARUNADR Return On Asset | 0.0499 |
Most of ASPEN PHARUNADR's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ASPEN PHARUNADR 1 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, ASPEN PHARUNADR 1 has a Return On Asset of 0.0499. This is 100.57% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all Germany stocks is 135.64% lower than that of the firm.
ASPEN PHARUNADR 1 Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ASPEN PHARUNADR's current stock value. Our valuation model uses many indicators to compare ASPEN PHARUNADR value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ASPEN PHARUNADR competition to find correlations between indicators driving ASPEN PHARUNADR's intrinsic value. More Info.ASPEN PHARUNADR 1 is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ASPEN PHARUNADR 1 is roughly 1.90 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ASPEN PHARUNADR's earnings, one of the primary drivers of an investment's value.ASPEN Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ASPEN PHARUNADR's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ASPEN PHARUNADR could also be used in its relative valuation, which is a method of valuing ASPEN PHARUNADR by comparing valuation metrics of similar companies.ASPEN PHARUNADR is currently under evaluation in return on asset category among its peers.
ASPEN Fundamentals
| Return On Equity | 0.095 | |||
| Return On Asset | 0.0499 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.23 % | |||
| Shares Outstanding | 444.95 M | |||
| Price To Earning | 24.16 X | |||
| Revenue | 38.61 B | |||
| Gross Profit | 18.29 B | |||
| EBITDA | 10.02 B | |||
| Net Income | 4.8 B | |||
| Cash And Equivalents | 8.55 B | |||
| Cash Per Share | 18.72 X | |||
| Total Debt | 24.87 B | |||
| Debt To Equity | 0.38 % | |||
| Current Ratio | 0.89 X | |||
| Book Value Per Share | 159.44 X | |||
| Cash Flow From Operations | 6.82 B | |||
| Earnings Per Share | 0.79 X | |||
| Number Of Employees | 8.58 K | |||
| Beta | 0.59 | |||
| Market Capitalization | 3.47 B | |||
| Annual Yield | 0.02 % | |||
| Last Dividend Paid | 3.26 |
About ASPEN PHARUNADR Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ASPEN PHARUNADR 1's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ASPEN PHARUNADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ASPEN PHARUNADR 1 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa. ASPEN PHAR is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Other Information on Investing in ASPEN Stock
ASPEN PHARUNADR financial ratios help investors to determine whether ASPEN Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ASPEN with respect to the benefits of owning ASPEN PHARUNADR security.